OMX Copenhagen PI
|
1 392,46
|
-16,56
|
-1,18 %
|
Analysen zu OMX Copenhagen PI-Werten
| 02.06.25 | Novo Nordisk Buy | UBS AG | |
| 02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.05.25 | Novo Nordisk Buy | UBS AG | |
| 19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.05.25 | A.P. Moeller - Maersk A-S Hold | Deutsche Bank AG | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 09.05.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 09.05.25 | Novo Nordisk Buy | UBS AG | |
| 08.05.25 | Novo Nordisk Halten | DZ BANK | |
| 08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 25.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.04.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.